Comparative expression of matrix metalloproteinases in internal malignancies and paired cutaneous metastatic lesions

Area of Science:

• Oncology
• Cancer Metastasis
• Molecular Biology

Background:

• Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and membrane-type 1 matrix metalloproteinase (MT1-MMP) are implicated in cancer cell invasion.
• These enzymes play a role in basement membrane degradation and stromal invasion during metastasis.

Purpose of the Study:

• To identify and compare the expression of MMPs and TIMPs in internal malignancies and their corresponding cutaneous metastatic lesions.
• To investigate differences in MMP-2, MMP-9, MT1-MMP, and TIMP-2 expression between primary cancers and skin metastases.

Main Methods:

• Immunohistochemical staining was employed to compare the expression levels of specific MMPs and TIMP-2.
• Expression patterns were analyzed in paired samples of internal malignancies and cutaneous metastatic lesions.
• Specific analyses were conducted for breast, lung, and stomach cancers.

Main Results:

• Cutaneous metastatic lesions exhibited significantly higher expression of MMP-2, MMP-9, and MT1-MMP, and lower expression of TIMP-2 compared to paired internal malignancies.
• In breast cancer, metastatic lesions showed increased MMP-9 and decreased TIMP-2.
• Lung cancer metastases had elevated MMP-2 and MT1-MMP, while stomach cancer metastases displayed reduced TIMP-2.

Conclusions:

• Cutaneous metastatic lesions display distinct MMP and TIMP-2 expression profiles compared to their primary internal tumors.
• The expression patterns of MMPs and TIMP-2 are influenced by the primary cancer type, suggesting tissue-specific metastatic behavior.